🔥🐔 BizChicken 🐔🔥
Companies Similar to Galectin Therapeutics Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Alector, Inc.
AL001, AL101, AL002, AL003, AL044
Alector, Inc. is a clinical stage biopharmaceutical company focused on developing therapies for neurodegeneration diseases. The company has several products in various stages of clinical trials aimed at treating conditions such as Alzheimer's, Parkinson's, and frontotemporal dementia.
About | Vision/Values | History | Leadership | Contact | Culture | Vision/Values | History | About | About | About | About | Careers | About | About
Symbol: ALEC
Recent Price: $1.72
Industry: Biotechnology
CEO: Dr. Arnon Rosenthal Ph.D.
Sector: Healthcare
Employees: 245
Address: 131 Oyster Point Boulevard, South San Francisco, CA 94080
Phone: 415 231 5660
Leadership
- Arnon Rosenthal, Ph.D., Co-Founder, Chief Executive Officer, and Director
- Sara Kenkare-Mitra, Ph.D., President and Head of Research and Development
- Marc Grasso, M.D., Chief Financial Officer
- Gary Romano, M.D., Ph.D., Chief Medical Officer
- Danielle Pasqualone, Ph.D., J.D., General Counsel
- Clare Hunt, M.B.A., Chief People Officer
- Kristina Cutter, M.P.H., Chief Regulatory, Pharmacovigilance, and Quality Assurance Officer
- Virginia DeJesus-Rueff, M.B.A., Chief of Staff and Head of Strategy
- Norah Conway, Senior Vice President, Portfolio and Program Management
- Neil Berkley, M.S., M.B.A., Chief Business Officer
- Louis J. Lavigne Jr., M.B.A., Chairperson of the Board
- Elizabeth Garofalo, M.D., Board Member
- Paula Hammond, Ph.D., Board Member
- Richard H. Scheller, Ph.D., Board Member
- David Wehner, Board Member
- Kristine Yaffe, M.D., Board Member
- Errol De Souza, Ph.D., Board Member
- Mark Altmeyer, M.B.A., Board Member
Last updated: 2024-12-31
BioAtla, Inc.
BA3011
Bio Atla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Their lead product candidate is BA3011, targeting various cancers.
Symbol: BCAB
Recent Price: $0.59
Industry: Biotechnology
CEO: Dr. Jay M. Short Ph.D.
Sector: Healthcare
Employees: 65
Address: 11085 Torreyana Road, San Diego, CA 92121
Phone: 858 558 0708
Last updated: 2024-12-31
Amicus Therapeutics, Inc.
Galafold
Amicus Therapeutics, Inc. is a biotechnology company focused on discovering, developing, and delivering medicines for rare diseases, with products including Galafold for Fabry disease and developing therapies for Pompe and CLN3 diseases.
Contact | About | About | Leadership | About | Leadership | About | Contact | Careers | Careers | Careers | Jobs | Careers | Directors | About | Jobs | Careers | About | About | About
Symbol: FOLD
Recent Price: $9.41
Industry: Biotechnology
CEO: Mr. Bradley L. Campbell M.B.A.
Sector: Healthcare
Employees: 500
Address: 3675 Market Street, Philadelphia, PA 19104
Phone: 215 921 7600
Leadership
- Bradley L. Campbell, President and Chief Executive Officer
- Simon Harford, Chief Financial Officer
- David Clark, Chief People Officer
- Jayne C. Gershkowitz, Chief Patient Advocate
- Sébastien Martel, Chief Business Officer
- Ellen S. Rosenberg, Chief Legal Officer
- Jeffrey P. Castelli, Chief Development Officer
- Stephen Arnold, Chief, Head of Global Rare Disease
- Julie Yu, Chief Program Officer
- Pat O’Sullivan, Chief Technical Operations Officer
- Jill Weimer, Chief Science Officer
- Patrik Florencio, Global Chief Compliance and Risk Officer
Last updated: 2024-12-31
Applied Therapeutics, Inc.
AT-007
Applied Therapeutics, Inc., a biopharmaceutical company, develops novel products targeting cardiovascular disease, galactosemia, and diabetic complications. Key products include AT-007 and AT-001.
About | Leadership | Leadership | Leadership | Leadership | Vision/Values | Culture | DEI | Contact | Contact | Careers | Careers | About | About | About
Symbol: APLT
Recent Price: $0.81
Industry: Biotechnology
CEO: Dr. Shoshana Shendelman Ph.D.
Sector: Healthcare
Employees: 31
Address: 545 Fifth Avenue, New York, NY 10017
Phone: 212 220 9226
Leadership
- Shoshana Shendelman, Chair, Board of Directors
- Riccardo Perfetti, Chief Medical Officer
- Les Funtleyder,
- Dale Hooks, Chief Commercial Officer
- Constantine Chinoporos, Chief Business Officer / Chief Operating Officer
- Joel Marcus,
- Jay Skyler,
- Stacy Kanter,
- Teena Lerner,
- Donald Landry M.D., Ph.D., Chair, Scientific Advisory Board
- Roy Freeman M.D.,
- Roxana Mehran M.D.,
- Lawrence Steinman M.D.,
- Gregg Stone M.D.,
- Donald d'Amico M.D.,
- Donald Landry, Chair, Scientific Advisory Board
- Roy Freeman,
- Roxana Mehran,
- Lawrence Steinman,
- Gregg Stone,
- Donald d'Amico,
Last updated: 2024-12-31
Arcellx, Inc.
CART-dd BCMA
Arcellx, Inc. is a clinical-stage biotechnology company dedicated to developing immunotherapies for cancer and other incurable diseases, with a focus on its lead product candidate, CART-dd BCMA, for treating relapsed or refractory multiple myeloma.
About | About | News | Contact | Contact | Culture | Culture | Culture | Culture | About | About | About | About | About | News
Symbol: ACLX
Recent Price: $78.35
Industry: Biotechnology
CEO: Mr. Rami Elghandour
Sector: Healthcare
Employees: 130
Address: 25 West Watkins Mill Road, Gaithersburg, MD 20878
Phone: 240 327 0603
Last updated: 2024-12-31
Apellis Pharmaceuticals, Inc.
pegcetacoplan
Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of therapeutic compounds targeting the complement system for autoimmune and inflammatory diseases.
About | Leadership | Directors | About | About | Contact | Contact | Contact | Culture | Benefits | Careers | Careers | About | About
Symbol: APLS
Recent Price: $31.90
Industry: Biotechnology
CEO: Dr. Cedric Francois M.D., Ph.D.
Sector: Healthcare
Employees: 702
Address: 100 Fifth Avenue, Waltham, MA 02451
Phone: 617 977 5700
Leadership
- Cedric Francois, MD, PhD, Co-Founder & Chief Executive Officer/President
- Caroline Baumal, MD, Chief Medical Officer
- Mark DeLong, Chief Business & Strategy Officer
- Pascal Deschatelets, PhD, Co-Founder & Chief Scientific Officer
- Jeffrey Eisele, PhD, Chief Development Officer
- Karen Lewis, Chief People Officer
- Nur Nicholson, Chief Technical Operations Officer
- Timothy Sullivan, Chief Financial Officer
- Adam Townsend, Chief Operating Officer
- David Watson, JD, General Counsel
- Apellis Pharmaceuticals,
- Gerald Chan, Chairman
- Sinclair Dunlop, Director
- Stephanie Monaghan O’Brien, Director
- Paul Fonteyne, Director
- Cedric Francois, Co-Founder & Chief Executive Officer/President
- Alec Machiels, Co-Founder
Last updated: 2024-12-31
Belite Bio, Inc
LBS-008
Belite Bio, Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics for age-related macular degeneration and Stargardt diseases. Its lead product candidate, LBS-008, is in phase 3 clinical trials.
Symbol: BLTE
Recent Price: $61.97
Industry: Biotechnology
CEO: Dr. Yu-Hsin Lin M.B.A., Ph.D.
Sector: Healthcare
Employees: 20
Address: 5820 Oberlin Drive, San Diego, CA 92121
Phone: 858-246-6240
Last updated: 2024-12-31
BioXcel Therapeutics, Inc.
IGALMI
Bio Xcel Therapeutics, Inc. is a biopharmaceutical company leveraging artificial intelligence for developing transformative medicines in neuroscience and immuno-oncology. It focuses on re-innovating existing drugs with machine learning to identify new therapeutic uses.
Symbol: BTAI
Recent Price: $0.37
Industry: Biotechnology
CEO: Dr. Vimal D. Mehta Ph.D.
Sector: Healthcare
Employees: 74
Address: 555 Long Wharf Drive, New Haven, CT 06511
Phone: 475 238 6837
Last updated: 2024-12-31
Cellectar Biosciences, Inc.
CLR 131
Cellectar Biosciences, Inc. is a clinical biopharmaceutical company concentrating on the development and commercialization of drugs for cancer treatment.
Symbol: CLRB
Recent Price: $0.29
Industry: Biotechnology
CEO: Mr. James V. Caruso
Sector: Healthcare
Employees: 20
Address: 100 Campus Drive, Florham Park, NJ 07932
Phone: 608 441 8120
Leadership
- James Caruso, President, CEO and Director
- Chad Kolean, Chief Financial Officer
- Shane Lea, Chief Commercial Officer
- Jarrod Longcor, Chief Operating Officer
- Andrei Shustov, Senior Vice President, Medical
- Douglas J. Swirsky, Chairman of the Board
- Asher Alban Chanan-Khan, MD., Director
- Frederick W. Driscoll, Director
- Stefan D. Loren, Ph.D., Director
- John Neis, Director
- Cellectar Biosciences, Inc., Company Information
Last updated: 2024-12-31
Galectin Therapeutics Inc.
belapectin (GR-MD-02)
Galectin Therapeutics Inc. engages in research and development of therapies for fibrotic, cancer, and other diseases, with a focus on developing galectin-3 inhibitors like belapectin.
Symbol: GALT
Recent Price: $1.10
Industry: Biotechnology
CEO: Mr. Joel Lewis
Sector: Healthcare
Employees: 14
Address: 4960 Peachtree Industrial Boulevard, Norcross, GA 30071
Phone: 678 620 3186
Last updated: 2024-12-31
Greenwich LifeSciences, Inc.
GP2
Greenwich Life Sciences, Inc. is a clinical stage biopharmaceutical company focusing on developing novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers, with a lead product candidate GP2, which aims to prevent breast cancer recurrences.
Symbol: GLSI
Recent Price: $10.91
Industry: Biotechnology
CEO: Mr. Snehal S. Patel
Sector: Healthcare
Employees: 3
Address: Building 14, Stafford, TX 77477
Phone: 832 819 3232
Last updated: 2024-12-31
GlycoMimetics, Inc.
uproleselan
Glyco Mimetics, Inc. is a clinical-stage biotechnology company that focuses on discovering and developing novel glycomimetic drugs to address unmet medical needs related to diseases, currently developing treatments for conditions such as acute myeloid leukemia and cancers affecting bone and bone marrow.
Symbol: GLYC
Recent Price: $0.25
Industry: Biotechnology
CEO: Mr. Harout Semerjian
Sector: Healthcare
Employees: 35
Address: 9708 Medical Center Drive, Rockville, MD 20850
Phone: 240 243 1201
Last updated: 2024-12-31
Gossamer Bio, Inc.
GB002, GB004, GB5121, GB7208
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics in immunology, inflammation, and oncology. Key products in development include GB002 for pulmonary arterial hypertension, GB004 for inflammatory bowel disease, GB5121 for primary central nervous system lymphoma, and GB7208 for multiple sclerosis.
About | About | Management | Directors | Contact | Locations | Contact | Contact | About | About
Symbol: GOSS
Recent Price: $0.88
Industry: Biotechnology
CEO: Mr. Faheem Hasnain
Sector: Healthcare
Employees: 135
Address: 3013 Science Park Road, San Diego, CA 92121
Phone: 858 684 1300
Leadership
- Faheem Hasnain, Chairman
- Richard Aranda, M.D., Chief Medical Officer
- Jeff Boerneke, General Counsel and Secretary
- Matt Cravets, Senior Vice President, Biometrics
- Bryan Giraudo, Chief Operating Officer & Chief Financial Officer
- Lisa Nolan, Ph.D., Managing Director and President, Gossamer Bio Ireland
- Caryn Peterson, Executive Vice President, Regulatory Affairs
- Bob Smith, Chief Commercial Officer
- Christian Waage, Executive Vice President, Technical Operations & Administration
- Deanna Weber, Senior Vice President, Human Resources
- Russell J. Cox, Director
- Thomas Daniel, Director
- Skye Drynan, Director
- Sandra Milligan, Director
- Steven D. Nathan, Director
- John Quisel, Director
Last updated: 2024-12-31
Structure Therapeutics Inc.
GSBR-1290
Structure Therapeutics Inc. develops novel oral therapeutics for chronic diseases with unmet medical needs, focusing on conditions like type-2 diabetes, obesity, pulmonary, and cardiovascular diseases.
Careers | Careers | Careers | Careers | Careers | About | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About
Symbol: GPCR
Recent Price: $26.63
Industry: Biotechnology
CEO: Dr. Raymond C. Stevens Ph.D.
Sector: Healthcare
Employees: 136
Address: 611 Gateway Boulevard, South San Francisco, CA 94080
Phone: 628-229-9277
Last updated: 2024-12-31
Pliant Therapeutics, Inc.
PLN-74809
Pliant Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on discovering, developing, and commercializing novel therapies for the treatment of fibrosis and related diseases. Their lead product candidate, PLN-74809, is currently in Phase 2a trials.
Symbol: PLRX
Recent Price: $12.79
Industry: Biotechnology
CEO: Dr. Bernard Coulie M.B.A., M.D., Ph.D.
Sector: Healthcare
Employees: 166
Address: 260 Littlefield Avenue, South San Francisco, CA 94080
Phone: 650 481 6770
Last updated: 2024-12-31
Regulus Therapeutics Inc.
RG-012 and RGLS8429
Regulus Therapeutics Inc., based in San Diego, focuses on discovering and developing drugs targeting micro RNAs for treating various diseases.
Symbol: RGLS
Recent Price: $1.50
Industry: Biotechnology
CEO: Mr. Joseph P. Hagan M.B.A.
Sector: Healthcare
Employees: 30
Address: 4224 Campus Point Court, San Diego, CA 92121
Phone: 858 202 6300
Last updated: 2024-12-31
SELLAS Life Sciences Group, Inc.
galinpepimut-S (GPS)
SELLAS Life Sciences Group, Inc. is a late-stage biopharmaceutical company focusing on the development of novel cancer immunotherapies in the United States. Their lead product candidate, galinpepimut-S (GPS), is in Phase III clinical trials for acute myeloid leukemia and Phase 1/2 for ovarian cancer.
Symbol: SLS
Recent Price: $0.99
Industry: Biotechnology
CEO: Dr. Angelos M. Stergiou M.D., ScD h.c.
Sector: Healthcare
Employees: 16
Address: Times Square Tower, New York, NY 10036
Phone: 646 200 5278
Last updated: 2024-12-31
Y-mAbs Therapeutics, Inc.
DANYELZA
Y-m Abs Therapeutics, Inc., is a commercial-stage biopharmaceutical company focused on developing and commercializing novel antibody-based therapeutic products for cancer treatment in the United States.
Symbol: YMAB
Recent Price: $7.76
Industry: Biotechnology
CEO: Mr. Michael Rossi
Sector: Healthcare
Employees: 100
Address: 230 Park Avenue, New York, NY 10169
Phone: 646 885 8505
Leadership
- Michael Rossi, President and Chief Executive Officer
- Thomas Gad, Founder, Vice Chairman of the Board of Directors, Chief Business Officer
- Torben Lund-Hansen, SVP, Chief Technical Officer
- Peter Pfreundschuh, Chief Financial Officer
- Vignesh Rajah, SVP, Chief Medical Officer
- Joris Wilms, SVP, Chief Operating Officer
- Sue Smith, SVP, Chief Commercial Officer
- Norman LaFrance, Chief Development Officer
- Johan Wedell-Wedellsborg, Chairman
- Ashutosh Tyagi, M.D.,
- James I. Healy, Chairman
- David N. Gill,
- Laura J. Hamill,
- Mary Tagliaferri, M.D.,
Last updated: 2024-12-31
Galecto, Inc.
GB2064
Galecto, Inc. is a clinical-stage biotechnology company focused on developing molecules for the treatment of fibrosis, cancer, inflammation, and related diseases. Their lead product candidate, GB2064, is in Phase IIa for myelofibrosis. The company also advances other candidates targeting severe fibrotic lung diseases and cancer.
Symbol: GLTO
Recent Price: $4.60
Industry: Biotechnology
CEO: Dr. Hans T. Schambye M.D., Ph.D.
Sector: Healthcare
Employees: 13
Address: 75 State Street, Boston, MA 02109
Phone: 457 070 5210
Last updated: 2024-12-31
Nektar Therapeutics
Bempegaldesleukin
Nektar Therapeutics is a biopharmaceutical company focused on developing medicines for unmet medical needs. Their products include Bempegaldesleukin, an IL-2 pathway agonist in clinical trials for various cancers and COVID-19, and NKTR-358, a cytokine Treg stimulant for autoimmune diseases.
About | Our Story | Leadership | Directors | About | Locations | Contact | Contact | Careers | Jobs | DEI | Careers | Careers | DEI | Careers | Careers | Jobs | Jobs | About | About
Symbol: NKTR
Recent Price: $0.94
Industry: Biotechnology
CEO: Mr. Howard W. Robin
Sector: Healthcare
Employees: 137
Address: 455 Mission Bay Boulevard South, San Francisco, CA 94158
Phone: 415 482 5300
Leadership
- Howard W. Robin, President & Chief Executive Officer
- Robert Bacci, Senior Vice President, HR and Facilities Operations
- Sandra Gardiner, Chief Financial Officer
- Jennifer Ruddock, Chief Business Officer
- Mary Tagliaferri, M.D., Chief Medical Officer
- Mark A. Wilson, Chief Legal Officer
- Jonathan Zalevsky, Ph.D., Chief Research & Development Officer
Last updated: 2024-12-31